BioGaia AB (publ) (STO:BIOG.B)
Sweden · Delayed Price · Currency is SEK 120.10
+3.00 (2.56%)
May 6, 2026, 5:29 PM CET
BioGaia AB Market Cap
BioGaia AB has a market cap or net worth of 12.15 billion as of May 6, 2026. Its market cap has increased by 18.56% in one year.
Market Cap
12.15B
Enterprise Value
11.37B
Revenue
1.54B
Ranking
n/a
PE Ratio
36.51
Stock Price
120.10
Market Cap Chart
Since December 31, 1998, BioGaia AB's market cap has increased from 181.00M to 12.15B, an increase of 6,612.41%. That is a compound annual growth rate of 16.62%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 5, 2026 | 11.85B | 10.26% |
| Dec 30, 2025 | 10.74B | -5.09% |
| Dec 30, 2024 | 11.32B | 10.77% |
| Dec 29, 2023 | 10.22B | 21.10% |
| Dec 30, 2022 | 8.44B | -19.33% |
| Dec 30, 2021 | 10.46B | -3.54% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Swedish Orphan Biovitrum AB | 149.34B |
| Cereno Scientific AB | 1.84B |
| EQL Pharma AB | 1.41B |
| Orexo AB | 649.54M |
| Enzymatica AB | 616.55M |
| Dicot Pharma AB | 601.20M |
| Nanexa AB | 549.71M |
| Cinclus Pharma Holding AB | 548.22M |